Does INSULIN LISPRO Cause Product packaging issue? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product packaging issue have been filed in association with INSULIN LISPRO (Humalog KwikPen). This represents 0.0% of all adverse event reports for INSULIN LISPRO.
5
Reports of Product packaging issue with INSULIN LISPRO
0.0%
of all INSULIN LISPRO reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging issue From INSULIN LISPRO?
Of the 5 reports, and 1 (20.0%) were considered life-threatening.
Is Product packaging issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN LISPRO. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN LISPRO Cause?
Blood glucose increased (31,969)
Incorrect dose administered (8,318)
Blood glucose decreased (6,439)
Drug ineffective (5,411)
Visual impairment (4,654)
Underdose (3,156)
Drug dose omission (3,063)
Glycosylated haemoglobin increased (2,482)
Blood glucose abnormal (2,460)
Malaise (2,204)
What Other Drugs Cause Product packaging issue?
ACETAMINOPHEN (448)
LOPERAMIDE (351)
DIMETHICONE\LOPERAMIDE (348)
USTEKINUMAB (221)
FENTANYL (200)
MINOXIDIL (173)
CETIRIZINE (166)
ESTRADIOL (163)
GOLIMUMAB (95)
CYCLOSPORINE (93)
Which INSULIN LISPRO Alternatives Have Lower Product packaging issue Risk?
INSULIN LISPRO vs INSULIN LISPRO-AABC
INSULIN LISPRO vs INSULIN NOS
INSULIN LISPRO vs INSULIN PORK\INSULIN PURIFIED PORK
INSULIN LISPRO vs INTERFERON
INSULIN LISPRO vs INTERFERON ALFA-2A